Short Interest in Nanovibronix, Inc. (NASDAQ:FEED) Expands By 359.0%

Nanovibronix, Inc. (NASDAQ:FEED) saw a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 344,075 shares, an increase of 359.0% from the July 30th total of 74,962 shares. Approximately 3.5% of the shares of the company are sold short. Based on an average trading volume of 3,043,455 shares, the days-to-cover ratio is currently 0.1 days.

Insider Buying and Selling

In other Nanovibronix news, insider Christian Michael Glibert sold 210,000 shares of Nanovibronix stock in a transaction dated Monday, June 22nd. The shares were sold at an average price of $0.69, for a total value of $144,900.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 12.20% of the company’s stock.

Nanovibronix Trading Down 7.3%

NASDAQ FEED traded down $0.03 during trading on Friday, hitting $0.34. 283,672 shares of the company’s stock were exchanged, compared to its average volume of 5,271,218. The stock’s 50 day moving average price is $0.45 and its two-hundred day moving average price is $1.20. Nanovibronix has a fifty-two week low of $0.29 and a fifty-two week high of $17.40. The company has a market cap of $3.78 million, a PE ratio of -0.03 and a beta of 1.38.

Nanovibronix (NASDAQ:FEED) last announced its quarterly earnings results on Monday, August 17th. The company reported ($1.98) earnings per share (EPS) for the quarter. The company had revenue of $0.24 million for the quarter. Nanovibronix had a negative net margin of 1,093.61% and a negative return on equity of 60.73%.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on the company. Wall Street Zen upgraded Nanovibronix from a “strong sell” rating to a “sell” rating in a research note on Sunday, July 12th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Nanovibronix in a research report on Tuesday, July 21st. One analyst has rated the stock with a Sell rating, According to MarketBeat, Nanovibronix currently has an average rating of “Sell”.

Nanovibronix Company Profile

Nanovibronix (NASDAQ: FEED) is a medical device company focused on the development and commercialization of non‑invasive therapeutic ultrasound technologies for clinical and consumer healthcare applications. The company’s product portfolio centers on wearable ultrasound devices designed to deliver low‑intensity acoustic energy to soft tissue with the objective of promoting wound healing and reducing pain. Nanovibronix positions its technology as an alternative or adjunct to conventional wound‑care and analgesic therapies, aiming to address chronic and acute conditions that are managed in both outpatient and home settings.

The company concentrates its commercial efforts on supplying hospitals, wound‑care clinics, long‑term care facilities and patients requiring home‑based therapies.